Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Eamonn O'Brien"'
Autor:
Laure Gossec, Philip J Mease, Xenofon Baraliakos, Laura C Coates, Helena Marzo-Ortega, Effie Pournara, Barbara Schulz, Roisin White, Eamonn O’Brien
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objectives To investigate patient characteristics predictive of response to secukinumab in patients with psoriatic arthritis (PsA) with axial manifestations.Methods In a post-hoc analysis from the MAXIMISE trial (NCT02721966) in patients with PsA and
Externí odkaz:
https://doaj.org/article/59466151ecd64fc4a58046b5177ac525
Autor:
Katlyn E. McGrattan, Richard D. Shell, Rebecca Hurst-Davis, Sally Dunaway Young, Eamonn O’Brien, Arseniy Lavrov, Shiri Wallach, Nicole LaMarca, Sandra P. Reyna, Basil T. Darras
Publikováno v:
Journal of Neuromuscular Diseases. :1-10
Background: Improvement and maintenance of bulbar function are goals of disease-modifying treatments for spinal muscular atrophy (SMA). Lack of standardized measures and a widely accepted definition of bulbar function represents a gap in SMA care. Ob
Publikováno v:
Oberwolfach Reports. 18:2027-2087
Autor:
Katlyn McGrattan, Richard Shell, Rebecca Hurst-Davis, Sally Dunaway Young, Giovanni Baranello, Arseniy Lavrov, Eamonn O’Brien, Shiri Wallach, Nicole LaMarca, Sandra P. Reyna, Basil Darras
Publikováno v:
Tuesday, April 25.
Autor:
Xenofon Baraliakos, Effie Pournara, Laura C Coates, Victoria Navarro-Compán, Ricardo Blanco, Eamonn O’Brien, Barbara Schulz, Robert Landewe
Objective The current analysis of the MAXIMISE trial was conducted to investigate the presence of post-inflammatory and degenerative spinal changes and inflammatory changes in spinal processes identified in baseline MRIs and their potential for predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4105721aec155d5446bbeab63980be40
https://doi.org/10.1093/rheumatology/kead162
https://doi.org/10.1093/rheumatology/kead162
Autor:
Laura C Coates, Xenofon Baraliakos, Effie Pournara, Laure Gossec, Helena Marzo-Ortega, Philip J Mease, Roisin White, Eamonn O'brien, Barbara Schulz
Publikováno v:
Rheumatology. 61
Background/Aims Psoriatic arthritis (PsA) is a heterogeneous disease with variability of response to different therapeutic modalities. Identifying potential demographic and disease characteristics as predictors of treatment response may define person
Autor:
Xenofon Baraliakos, Effie Pournara, Laure Gossec, Philip J Mease, Roisin White, Eamonn O’Brien, Barbara Schulz, Helena Marzo-Ortega, Laura C Coates
Publikováno v:
RMD Open. 8:e002303
ObjectivesTo investigate patient characteristics predictive of response to secukinumab in patients with psoriatic arthritis (PsA) with axial manifestations.MethodsIn a post-hoc analysis from the MAXIMISE trial (NCT02721966) in patients with PsA and a
Autor:
Ruben Marques, Beatrice Vincenzi, Rosario Pivonello, Annamaria Colao, Shobha Manne, Antoine Tabarin, Gregory Kaltsas, Tomaz Kocjan, Moreno Eva Venegas, Christof Schöfl, Katarzyna Krzyzanowska-Mittermayer, Wolfram Karges, Ansgar Heck, Eamonn O’Brien, Inmaculada Gonzalez-Molero, Engstrom Britt Eden, Sebastian Neggers
Publikováno v:
Endocrine Abstracts.
Probabilistic Group Theory, Combinatorics and Computing is based on lecture courses held at the Fifth de Brún Workshop in Galway, Ireland in April 2011. Each course discusses computational and algorithmic aspects that have recently emerged at the in
Autor:
Daniel J. Rader, Andrew Rut, Pieter Hendrik Evert Groot, Warren B. Gefter, Nigel Kay Spurr, Eamonn O’Brien, Megan L. Wolfe, Ana M. Valdes
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 22:1924-1928
Objective— Studies in mice have shown that genetic disruption of monocyte chemotactic protein-1 or its receptor, the C-C chemokine receptor 2 (CCR2), inhibits atherosclerosis, but few data exist in humans to suggest that the monocyte chemotactic pr